EUVIMEDEUVIMED entdecken
Open Access

Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure

Masahiro Kamo, Rintaro Sogawa, Chisato Shimanoe

In Vivo · 2024

DOI: 10.21873/invivo.13637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Masahiro Kamo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Saga University Hospital, Saga, Japan. Hauptthemen laut MEDLINE: Acute Kidney Injury, Antiviral Agents, COVID-19 Drug Treatment, Adenosine Monophosphate. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryAntiviral AgentsCOVID-19 Drug TreatmentAdenosine MonophosphateAlanineSARS-CoV-2COVID-19RitonavirHumansFemaleMaleMiddle AgedAgedRisk FactorsAdultDrug CombinationsAdenosine

Stichwörter der Autor:innen

Coronavirus disease 2019acute kidney injurypharmacovigilance

Substanzen

Antiviral AgentsremdesivirAdenosine MonophosphateAlanineRitonavirGS-441524Drug CombinationsAdenosine

Autor:innen und Institutionen

  • Department of Pharmacy, Saga University Hospital, Saga, Japan.
  • Department of Pharmacy, Saga University Hospital, Saga, Japan sogawari@cc.saga-u.ac.jp.

Zitieren

APA

Kamo, M., Sogawa, R., & Shimanoe, C. (2024). Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure. In Vivo. https://doi.org/10.21873/invivo.13637

Vancouver

Kamo M, Sogawa R, Shimanoe C. Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure. In Vivo. 2024. doi:10.21873/invivo.13637

BibTeX
@article{Kamo2024,
  author = {Kamo, Masahiro and Sogawa, Rintaro and Shimanoe, Chisato},
  title = {Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13637}
}
Kostenlos starten →